Picture of Sensorion SA logo

ALSEN — Sensorion SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Sensorion Signs Partnership Framework Agreement With Institut Pasteur On Gene Therapy Programs

May 27 (Reuters) - SENSORION SA  ALSEN.PA :
    * SENSORION ANNOUNCES THE SIGNATURE OF A PARTNERSHIP
FRAMEWORK
AGREEMENT WITH INSTITUT PASTEUR ON GENE THERAPY PROGRAMS
TARGETING HEARING LOSS
    * AGREEMENT DEFINES AN EXCLUSIVE OPTION TO OBTAIN LICENCES
FOR
JOINT PROGRAMS INCLUDING OTOFERLIN & USHER TYPE 1
    * AGREEMENT DEFINES PREFERENCE RIGHTS ON RESEARCH PIPELINE
IN
FIELD OF GENETIC DISORDERS OF INNER EAR IN ORDER TO SET UP
FUTURE COLLABORATIONS

Source text for Eikon:  ID:nBw6Z3fD0a 
Further company coverage:  ALSEN.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))

Recent news on Sensorion SA

See all news